Redmile Group’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.05M | Sell |
630,686
-178,729
| -22% | -$1.43M | 0.54% | 34 |
|
|
2025
Q1 | $7.9M | Hold |
809,415
| – | – | 0.75% | 28 |
|
|
2024
Q4 | $10.2M | Buy |
809,415
+746,348
| +1,183% | +$9.43M | 0.71% | 32 |
|
|
2024
Q3 | $1.01M | Sell |
63,067
-4,018
| -6% | -$64.6K | 0.06% | 61 |
|
|
2024
Q2 | $1.64M | Sell |
67,085
-15,715
| -19% | -$383K | 0.1% | 57 |
|
|
2024
Q1 | $5.95M | Buy |
82,800
+36,953
| +81% | +$2.65M | 0.22% | 67 |
|
|
2023
Q4 | $9.11M | Sell |
45,847
-7,589
| -14% | -$1.51M | 0.33% | 53 |
|
|
2023
Q3 | $7.1M | Sell |
53,436
-554
| -1% | -$73.7K | 0.34% | 50 |
|
|
2023
Q2 | $8.08M | Sell |
53,990
-32,027
| -37% | -$4.79M | 0.31% | 52 |
|
|
2023
Q1 | $12.6M | Sell |
86,017
-12,087
| -12% | -$1.77M | 0.55% | 51 |
|
|
2022
Q4 | $15.5M | Hold |
98,104
| – | – | 0.64% | 42 |
|
|
2022
Q3 | $18.9M | Sell |
98,104
-4,125
| -4% | -$794K | 0.73% | 40 |
|
|
2022
Q2 | $14.9M | Buy |
102,229
+8,644
| +9% | +$1.26M | 0.57% | 43 |
|
|
2022
Q1 | $16.5M | Buy |
+93,585
| New | +$16.5M | 0.51% | 47 |
|